Skip to Main Content
×
Quiver Logo Get a Free Trial on Quiver Premium Today!
Back to News

CYTOSORBENTS ($CTSO) Releases Q4 2025 Earnings

None

CYTOSORBENTS ($CTSO) posted quarterly earnings results for Q4 2025 on Wednesday, March 25th. The company reported earnings of -$0.09 per share, missing estimates of -$0.05 by $0.04. The company also reported revenue of $9,230,000, missing estimates of $9,778,403 by $-548,403.

You can see Quiver Quantitative's $CTSO stock page to track data on insider trading, hedge fund activity, congressional trading, and more.

CYTOSORBENTS Hedge Fund Activity

We have seen 22 institutional investors add shares of CYTOSORBENTS stock to their portfolio, and 20 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

  • PATHSTONE HOLDINGS, LLC added 499,955 shares (+inf%) to their portfolio in Q4 2025, for an estimated $319,571
  • SKYLANDS CAPITAL, LLC removed 272,750 shares (-12.8%) from their portfolio in Q4 2025, for an estimated $174,341
  • CM MANAGEMENT, LLC added 188,372 shares (+14.6%) to their portfolio in Q4 2025, for an estimated $120,407
  • AVENIR CORP added 147,261 shares (+2.9%) to their portfolio in Q4 2025, for an estimated $94,129
  • SARGENT INVESTMENT GROUP, LLC removed 126,700 shares (-17.2%) from their portfolio in Q4 2025, for an estimated $80,986
  • CITADEL ADVISORS LLC added 83,589 shares (+127.2%) to their portfolio in Q4 2025, for an estimated $53,430
  • KESTRA ADVISORY SERVICES, LLC removed 38,828 shares (-60.2%) from their portfolio in Q4 2025, for an estimated $24,818

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

CYTOSORBENTS Analyst Ratings

Wall Street analysts have issued reports on $CTSO in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

  • D. Boral Capital issued a "Buy" rating on 11/14/2025

To track analyst ratings and price targets for CYTOSORBENTS, check out Quiver Quantitative's $CTSO forecast page.

CYTOSORBENTS Price Targets

Multiple analysts have issued price targets for $CTSO recently. We have seen 2 analysts offer price targets for $CTSO in the last 6 months, with a median target of $5.375.

Here are some recent targets:

  • Jason Kolbert from D. Boral Capital set a target price of $10.0 on 01/12/2026
  • Sean Lee from HC Wainwright & Co. set a target price of $0.75 on 11/14/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

Check out the Quiver Quantitative API to build on top of data on congressional stock trading, insider transactions, hedge fund moves, and more.

Add Quiver Quantitative to your preferred sources on Google Google News Logo

Suggested Articles